Skip to main content
Equibles

GTS SECURITIES LLC

Broker-Dealer

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1452765 NEW YORK, NY
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$102,680
-$54,613 QoQ
Shares Held
30,200
-3.8% QoQ
Ownership
0.335%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 31 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $5,249,889 across 19 Biotechnology names. LSTA ranks #12 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 1,164 $1,079,924
2 GMAB
Genmab A/S
 32,116 $882,226
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,060 $526,533
4 ALNY
Alnylam Pharmaceuticals, Inc.
 1,452 $437,095
5 TBPH
Theravance Biopharma, Inc.
 25,320 $430,440
6 TLX
Telix Pharmaceuticals Ltd
 35,537 $409,741
7 REGN
Regeneron Pharmaceuticals, Inc.
 626 $390,336
8 BHVN
Biohaven Ltd.
 16,988 $252,781

All Filings in LSTA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $102,680 30,200
2026-03-31 $157,293 31,396